|
|
Volumn 1, Issue 4, 2000, Pages 219-
|
|
Phase I trials in cancer treatment. The maximum tolerated dose: a barbarian guideline.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EDITORIAL;
HUMAN;
HUMAN EXPERIMENT;
INFORMED CONSENT;
LEGAL ASPECT;
MAXIMUM TOLERATED DOSE;
MEDICAL ETHICS;
NEOPLASM;
PHASE 1 CLINICAL TRIAL;
PROGNOSIS;
PSYCHOLOGICAL ASPECT;
STANDARD;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE I;
ETHICS, MEDICAL;
HUMAN EXPERIMENTATION;
HUMANS;
INFORMED CONSENT;
MAXIMUM TOLERATED DOSE;
NEOPLASMS;
PROGNOSIS;
|
|
EID: 19044400143
PISSN: 14664860
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.thj.6200048 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|
